CompletedNCT03755895
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients
Medication studyAges 18–80France
Understand this study
Who was this study for?
Listed age limits: 18 years to 80 years.
- Listed locations
- Vandœuvre-lès-NancySee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: November 2, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 68
- Sponsor
- Institut de Cancérologie de Lorraine
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT03755895
- Official title
Show the full official title
Randomized Trial Comparing the Hypnosis Versus Standard Care of Anxiety and Pain in Patients With Brachytherapy
Get this study by email
Recruitment & locations
CompletedVandœuvre-lès-Nancy
Questions about this study
Who is behind this study?
The study sponsor is Institut de Cancérologie de Lorraine, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Kalinox.
Who was this study for?
Listed age limits: 18 years to 80 years.
Want to explore more studies?
Explore studiesRelated studies
A double-blind, randomised, placebo-controlled, multicentre, relapse-prevention study with Lu AA21004 in patients with Generalised Anxiety Disorder (GAD)
Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo